Doc Alan
22nd December 2014, 19:35
• The 100,000 Genome Project ( 100 KGP ) is a plan to sequence whole genomes ( complete sets of genes ) by " Genomics England " on cancer patients, individuals with rare genetic diseases, and their relatives. This is an NHS project initially for patients from England, but later hopefully elsewhere in the UK. It’s already had a small " test run " this year. Genomics England is owned and funded by the Department of Health.
• Eleven hospitals across England will start recruiting patients in the New Year.
• For over a decade the Human Genome Project has meant it’s been possible to sequence the DNA sequence of humans. Now it can be done in a few days for under £ 1,000. The NHS is well placed to link a patient’s medical record with their genome data. Clearly patients need to give informed consent, and the system must be as secure and anonymous as possible, so that individuals can’t be identified, unless the data is to be used by their own doctor for their treatment.
• This is NOT the same as screening of apparently healthy people with no significant family history of cancer or genetic disease.
• Cancer – purposeless proliferation of cells – is all about genes and DNA mutations in what were previously normal cells. There are many different kinds of cancer, and an increasing number can be cured. " Making war on ", or " the battle against ", cancer is neither helpful or accurate !
• Already what we know has helped us understand the dozen or so different types of breast cancer and allowed use of a drug for one type – so-called personalised medicine. Similarly, by studying other known genetic diseases we will find more about mutations / changes which could be used to develop new treatments.
• Of course there are concerns around privacy and confidentiality, together with ensuring the UK tax payer will benefit if companies successfully develop diagnostic tests, drugs, devices, and treatments through use of the data. 110 KGP will also mean more work for geneticists !
• This really DOES seem to be the future for healthcare – personalised treatment based on an individual patient’s genome ; which will allow " targeted drugs " ; radiotherapy ; and even tracking of infections ( by looking at genomes of bugs ).
• 100 KGP is not guaranteed to succeed. Most medics hope it will. The future lies in precise, safer, effective treatment – not " one size fits all medicine " , which surely belongs to the past. It’s good news that OUR NHS is involved in the forefront of science, allowing us to more accurately prevent, diagnose and treat cancers and other genetic diseases - a revolution which should benefit patients in England, the rest of the UK, and elsewhere in the world :xxgrinning--00xx3:.
http://www.genomicsengland.co.uk/the-100000-genomes-project/
• Eleven hospitals across England will start recruiting patients in the New Year.
• For over a decade the Human Genome Project has meant it’s been possible to sequence the DNA sequence of humans. Now it can be done in a few days for under £ 1,000. The NHS is well placed to link a patient’s medical record with their genome data. Clearly patients need to give informed consent, and the system must be as secure and anonymous as possible, so that individuals can’t be identified, unless the data is to be used by their own doctor for their treatment.
• This is NOT the same as screening of apparently healthy people with no significant family history of cancer or genetic disease.
• Cancer – purposeless proliferation of cells – is all about genes and DNA mutations in what were previously normal cells. There are many different kinds of cancer, and an increasing number can be cured. " Making war on ", or " the battle against ", cancer is neither helpful or accurate !
• Already what we know has helped us understand the dozen or so different types of breast cancer and allowed use of a drug for one type – so-called personalised medicine. Similarly, by studying other known genetic diseases we will find more about mutations / changes which could be used to develop new treatments.
• Of course there are concerns around privacy and confidentiality, together with ensuring the UK tax payer will benefit if companies successfully develop diagnostic tests, drugs, devices, and treatments through use of the data. 110 KGP will also mean more work for geneticists !
• This really DOES seem to be the future for healthcare – personalised treatment based on an individual patient’s genome ; which will allow " targeted drugs " ; radiotherapy ; and even tracking of infections ( by looking at genomes of bugs ).
• 100 KGP is not guaranteed to succeed. Most medics hope it will. The future lies in precise, safer, effective treatment – not " one size fits all medicine " , which surely belongs to the past. It’s good news that OUR NHS is involved in the forefront of science, allowing us to more accurately prevent, diagnose and treat cancers and other genetic diseases - a revolution which should benefit patients in England, the rest of the UK, and elsewhere in the world :xxgrinning--00xx3:.
http://www.genomicsengland.co.uk/the-100000-genomes-project/